Tuesday, April 8, 2025

Hybrid Conference | 1 Cat. 1
Date: Tuesday, April 8, 2025
Time: 5:30 p.m. - 8:00 p.m.
Location:

• In-person: Miami Cardiac & Vascular Institute Conference Room, 5th floor, Baptist Hospital campus
• Virtual: Via Zoom

AL amyloidosis is a complex plasma cell disorder that poses significant diagnostic and therapeutic challenges. Please join us at this special event to hear renowned expert Vaishali Sanchorawala, M.D., provide an in-depth review of AL amyloidosis, including its pathophysiology, recent therapeutic advances, and evolving practice standards. Participants will explore strategies to enhance patient-centered care and assess clinical trial eligibility to optimize patient management and outcomes.

 

MORE INFORMATION AND REGISTER >>

Upon completion of this conference, participants should be better able to:

• Explain the pathophysiology of the plasma cell disorder AL amyloidosis to enhance understanding of disease mechanisms.
• Analyze recent data on therapeutic advances and evolving practice standards in AL amyloidosis and integrate this information into the selection of optimal systemic therapies for patients.
• Implement strategies to enhance patient-centered care.
• Evaluate the design and eligibility criteria of ongoing clinical trials for AL amyloidosis and facilitate appropriate patient enrollment or referral.

Who Should Attend

Cardiologists, hematologists, nephrologists, primary care physicians, general internists, neurologists, physician assistants, advanced practice registered nurses, hospitalists, nurses, pharmacists and techs, respiratory therapists and other interested healthcare providers.